Institutional investors purchased a net $47.2 thousand shares of OPK during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 19.12% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TWO SIGMA INVESTMENTS LLC Bought 1.5 Million shares of OPKO Health Inc
D. E. SHAW & CO. LP Bought 1.4 Million shares of OPKO Health Inc
THE VANGUARD GROUP, INC. Bought 1.2 Million shares of OPKO Health Inc